Price target upside
BridgeBio Pharma Price Target Upside or Downside
BBIO price target upside based on the current price and analyst average.
Direct answer
BridgeBio Pharma's analyst target implies +29.4%.
The average target is $106.19 compared with a recorded current price of $82.07.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $82.07
- Average price target
- $106.19
- High price target
- $157.00
- Low price target
- $80.00
- Target upside
- +29.4%
- Consensus rating
- Strong Buy
- Analysts
- 21
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026